Skip to content
20-F

Annual Report (Foreign)

AVRICORE HEALTH INC. AVCRF

0001641172-25-015266

← back to feed
Filed
Jun 16, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Dec 31, 2024 100.31M sh
Shares Diluted FY 2024 · Dec 31, 2023 99.56M sh
Shares Diluted FY 2024 · Dec 31, 2022 97.86M sh
Shares Outstanding FY 2024 · Dec 31, 2024 101.29M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 1M
Operating Cash Flow FY 2024 · Dec 31, 2023 660.4K
Operating Cash Flow FY 2024 · Dec 31, 2022 −437.83K
Cash And Equivalents FY 2024 · Dec 31, 2024 1.13M
Cash And Equivalents FY 2024 · Dec 31, 2023 276.57K
Cash And Equivalents FY 2024 · Dec 31, 2022 620.53K
Cash And Equivalents FY 2024 · Dec 31, 2021 2.01M
Stockholders Equity FY 2024 · Dec 31, 2024 1.97M
Stockholders Equity FY 2024 · Dec 31, 2023 2.01M
Stockholders Equity FY 2024 · Dec 31, 2022 1.96M
Stockholders Equity FY 2024 · Dec 31, 2021 2.2M
Total Liabilities FY 2024 · Dec 31, 2024 330.82K
Total Liabilities FY 2024 · Dec 31, 2023 529.22K
Current Assets FY 2024 · Dec 31, 2024 1.58M
Current Assets FY 2024 · Dec 31, 2023 773.56K
Total Assets FY 2024 · Dec 31, 2024 2.3M
Total Assets FY 2024 · Dec 31, 2023 2.54M
Eps Diluted FY 2024 · Dec 31, 2024 −0.01
Eps Diluted FY 2024 · Dec 31, 2023 −0.01
Eps Diluted FY 2024 · Dec 31, 2022 −0.01
Eps Basic FY 2024 · Dec 31, 2024 −0.01
Eps Basic FY 2024 · Dec 31, 2023 −0.01
Eps Basic FY 2024 · Dec 31, 2022 −0.01
Gross Profit FY 2024 · Dec 31, 2024 1.88M
Gross Profit FY 2024 · Dec 31, 2023 1.2M
Gross Profit FY 2024 · Dec 31, 2022 456.79K
Cost Of Revenue FY 2024 · Dec 31, 2024 2.91M
Cost Of Revenue FY 2024 · Dec 31, 2023 2.28M
Cost Of Revenue FY 2024 · Dec 31, 2022 1.31M